COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • COPSACDailyGutcohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌

2023 Julie Kyvsgaard – MD

  • 2015 Ann-Marie Malby Schoos, MD PhD
    • Thesis_2015_Ann-Marie_Schoos
  • 2014 Marie Kragh, MSc PhD
    • Thesis_2014_Marie-Kragh.pdf
  • 2014 Eskil Kreiner-Møller, MD PhD
    • Thesis_2014_Eskil-Kreiner-Moller
  • 2014 Nadja Hawwa Vissing, MD PhD
    • Thesis_2014_Nadja-Vissing
  • 2014 Anna Hammerich Thysen, Msc PhD
    • Thesis_2014_Anna-Thysen
  • 2013 Charlotte Giwercman Carson MD, PhD
    • Thesis_2013_Charlotte-Giwercman
  • 2013 Anne Louise Bischoff MD, PhD
    • Thesis_2013_Anne-Bischoff
  • 2012 Louise Pedersen, MD, PhD
    • Thesis_2012_Louise-Pedersen
  • 2012 Jakob Stokholm, MD, PhD
    • Thesis_2012_Jakob-Stokholm
  • 2012 Nilofar Følsgaard, MD, PhD
    • Thesis_2012_Nilo-Foelsgaard
  • 2011 Martin Brasholt, MD, PhD
    • Thesis_2011_Martin-Brasholt
  • 2011 Bo Chawes, MD, PhD
    • Thesis_2011_Bo-Chawes
  • 2010 Klaus Bønnelykke, MD, PhD
    • Thesis_2010_Klaus-Bonnelykke
  • 2010 Porntiva Poorisrisak, MD, PhD
    • Thesis_2010_Porntiva-Poorisrisak
  • 2009 Mette N Hermansen, MD, PhD
    • Thesis_2009_Mette-Hermansen
  • 2006 Liselotte B Halkjær, MD, PhD
    • Thesis_2006_Liselotte-Halkjær
  • 2006 Birgitte Boysen Kjær, MD, PhD
  • 2004 Lotte Loland, MD, PhD
    • Thesis_2004_Lotte-Loland
  • 2002 Frederik F Buchvald, MD, PhD
    • Thesis_2002_Frederik-Buchvald
  • 1999 Marianne Stubbe Østergaard, MD, PhD
  • 1993 Jytte Fogh, MD, PhD
  • 2017 Elín Bjarnadóttir, MD PhD
  • 2017 Helene Wolsk, MD
  • 2017 Tine Marie Pedersen, MD
  • 2017 Astrid Sevelsted, MSc
  • 2017 Rebecca Kofod Vinding, MD
  • 2019 Lambang Arianto, MD
  • 2018 Henrik Hallas, MD
  • 2018 Jonathan Thorsen, MD
  • 2018 Nadia Rahman Fink, MD
  • 2019 Christian Carlsson, MD
  • 2019 Christian Carlsson, MD
  • 2019 Ni Wang, MD
  • 2021 Sarah Nørgaard – MSc
  • 2020 Asja Kunøe – MD
  • 2021 Nicklas Brustad – MD
  • 2021 Anders Eliasen – MSc
  • 2021 Lærke Sass – MD
  • 2022 Pia Nørrisgaard – MSc
  • 2022 Emil Christensen – MD
  • 2023 Rikke Sunde – MD
  • 2023 Julie Kyvsgaard – MD
  • 2024 Yang Luo – MSc
  • 2024 Julie Rosenberg – MD
  • 2024 Christina Poulsen – MSc
  • 2024 Parisa Mohammadzadeh – MD
  • 2024 Signe Jensen – MD
  • 2024 David Horner – MD
  • 2025 Liang Chen
  • 2025 Sarah Brandt
  • 2025 Kasper Rasmussen
  • 2025 Mathias Melgaard
  • 2026 Michael Widdowson
  • 2026 Jie Jiang
  • 2026 Kristina Aagaard
  • 2026 Frederikke Skov
  • 2026 Trine Mølbæk-Engbjerg
  • 2026 Kasper Fischer-Rasmussen
  • 2026 Tamo Sultan
Home Home Dissemination Theses 2023 Julie Kyvsgaard – MD

Interplay between Risk Factors of Asthma-Like symptoms, Early-Life Infections, and Risk of Asthma

By Julie Kyvsgaard

Summary

Chair person: Klaus Müller

Opponent: Varpu Elenius

Opponent: Sune Leisgaard Mørck Rubak

ABSTRACT

Asthma-like symptoms, including cough, wheeze, and breathlessness, are common in preschool children and often result in hospitalisation. These symptoms can be a significant burden for the children, their families, and the society. Although risk factors for childhood asthma have been extensively studied, there is a notable gap in research regarding their impact on the prevalence of asthma-like episodes during early childhood and whether such effects vary with age.

Respiratory tract infections (RTIs) are well-known triggers for episodes with asthma-like symptoms in early childhood, which may suggest that risk factors of asthma-like episodes in this period of life could be explained by an increased infection susceptibility. Further, early-life RTIs, especially more severe lower RTIs requiring hospitalisation or physician-attendance, have been linked to the development of asthma and reduced lung function later in life. However, we still need further studies focusing on how the burden of common infections in early childhood, including specific subtypes of infections, influences the risk of developing asthma. Additionally, it is unknown whether the various risk factors exert their asthma associations through an increased burden of infections in early life.
Finally, some studies have suggested a synergistic effect between early-life RTIs and atopy in relation to risk of asthma, but further investigations are needed to fully understand the complex interactions between infection burden, allergic traits, and asthma risk.

This PhD thesis is based on data collected from the COpenhagen Prospective Studies on Asthma in Childhood 2010 (COPSAC2010), a population-based prospective mother-child cohort, which consist of 700 children. The main objectives of the thesis were:

  1. To investigate risk factors for the number of asthma-like episodes from birth up to age 3 years and determine if these risk factors exert an age-specific pattern.
  2. To explore whether the identified risk factors for the burden of asthma-like episodes at ages 0−3 years exert their effect through an increased infection burden.
  3. To examine if the burden of common infections, including their specific subtypes, in early life associate with the risk of later asthma and reduced lung function. Additionally, to explore the interaction between the burden of infections and respiratory allergy in relation to asthma risk.

In Paper I we assessed the influence of various of pre-, peri, and postnatal variables on risk of asthma-like episodes from birth to 3 years. These episodes were recorded prospectively in daily diary cards by the parents. Furthermore, we explored the age-related impact of these risk factors on the frequency of asthma-like episodes.

We found that several variables—including male sex, low birth weight, maternal asthma, maternal antibiotic use, a high asthma exacerbation polygenic risk score (PRS), and a high airway immune score—were correlated with an elevated number of asthma-like episodes from birth up to age 3 years. Interactions highlighted that the impact of maternal asthma, preterm birth, caesarean section (C-section), and low birth weight grew with increasing age. In contrast, having sibling(s) at birth showed a decreasing impact with increasing age. A combined risk factor score based on the clinical risk factors available at birth, comprising male sex, low birth weight and maternal asthma, demonstrated a stepwise increase in the risk of experiencing more episodes.

In conclusion, using unique diary-recordings, we identified several risk factors for asthma-like episodes and revealed their age-related patterns. This aids knowledge to the aetiology of the burden of asthmatic symptoms in early life and could potentially contribute to a more personalised prognosis and treatment approach.

In Paper II, we investigated if the established risk factors for asthma-like episodes from birth to age 3 years were mediated by an increased infection burden. This infection data was also recorded prospectively by the parents using daily diary cards, which encompassed details on specific subtypes of infections.

Our findings revealed that the heightened burden of common infections partially mediated the impact of certain risk factors on the frequency of asthma-like episodes. Specifically, the associations with maternal asthma, antibiotic use during pregnancy, sibling(s) at birth, the asthma exacerbation PRS, and the airway immune score were all partially mediated through an increased infection burden. The infection subtypes responsible for this pattern included colds, pneumonia, gastroenteritis, and fever episodes. However, acute otitis media (AOM) and acute tonsillitis did not mediate any of the associations. Interestingly, factors like male sex, low birth weight, and maternal antibiotic use after birth did not have a mediating effect by infectious episodes.

In conclusion, our study indicates that many risk factors determining the burden of asthma-like episodes in early childhood partially act through an increased susceptibility to infections. This suggests that implementing preventive strategies against early-life infections could potentially lower the burden of asthma-like symptoms.

In Paper III, we explored the influence of the burden and subtypes of infections during early life on the risk of developing asthma and diminished lung function up to age 10 years. Additionally, we examined the synergistic relationship between early-life infection burden and respiratory allergy concerning subsequent asthma development.

We discovered that a high burden of infections during early years was associated with an increased risk of asthma from ages 3 to 10 years. Notably, the infection subtypes that drove this association were colds, pneumonia, gastroenteritis, and fever episodes, whereas AOM or acute tonsillitis did not exhibit such a linkage. Further, a higher infection burden was not correlated adverse lung function measures. Though, burden with pneumonia predicted lower Forced expiratory volume in the first second (FEV1) and maximal mid expiratory flow (MMEF). Interestingly, we found no direct association between infection burden or subtypes and allergic rhinitis at age 6 years. However, in relation to asthma risk, a significant interaction between cold burden and allergic rhinitis was observed, showing a significantly higher risk of asthma in children with allergic rhinitis compared to those without.
To conclude, children exposed to a high burden of infections—particularly colds, pneumonia, gastroenteritis, and fever—in the first 3 years of life are at increased risk of asthma, especially if they also develop allergic rhinitis. Our insights support the potential of preventing early-life infections prevention as strategy to reduce the risk of asthma.

The first 2 studies provide valuable insights into the origins of asthma-like symptoms in early childhood by identifying risk factors, exploring their age-related patterns, and investigating their effect through early-life infections. The 3rd study contributes to our understanding how burden and subtypes of early-life infections correlate with the later risk of asthma and lung function measures. Furthermore, we illustrate how early-life burden with colds and the onset of allergic rhinitis interact in terms of asthma risk, which supports the so-called “two-hit hypothesis”. Overall, our findings suggest that implementing preventive strategies targeting early-life infections could diminish the burden of asthma-like episodes in early childhood and later asthma risk, particularly in individuals at high risk.


CONTACT

COPSAC
Copenhagen Prospective Studies on Asthma in Childhood
Copenhagen University Hospital, Herlev-Gentofte
phone +45 3867 7360
contact@copsac.com
COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • COPSACDailyGutcohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌
COPSAC